<--- Back to Details
First PageDocument Content
Muscular dystrophy / Cytoskeleton / Pharmaceutical industry / Pharmacology / Pharmacy / National Institutes of Health / Dystrophin / Conflict of interest / Biology / Medicine / Health
Muscular dystrophy
Cytoskeleton
Pharmaceutical industry
Pharmacology
Pharmacy
National Institutes of Health
Dystrophin
Conflict of interest
Biology
Medicine
Health

Disclosure Form: Jeffrey Chamberlain

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 40,18 KB

Share Document on Facebook

Similar Documents

Cell Biology and Cancer under a contract from the National Institutes of Health in collaboration with the National Cancer Institute

DocID: 1vqc4 - View Document

SCIENCE & TECHNOLOGY POLICY IN STITUTE Technology Development at the National Institutes of Health (NIH): Summary Report Brian L. Zuckerman

DocID: 1v9kv - View Document

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Heart, Lung, and Blood Institute (NHLBI)

DocID: 1v3b2 - View Document

Conference Organizers James Prestegard, CFG and University of Georgia Michael Tiemeyer, CFG and University of Georgia John Hanover, CFG and National Institutes of Health Joyce Taylor-Papadimitriou, CFG and King’s Colle

DocID: 1v07l - View Document

Nematode sperm motility* Harold E. Smith§ National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD, USA Table of Contents

DocID: 1uVU8 - View Document